P3 Health Partners Inc. PIII
4.25 USD +0.25 (+6.25%)
At closeNov 9, 2026, 4:00 PM EST
4.60 +0.35 +8.24%
After hours · Nov 9, 4:00 PM ET
4.02 Day range 4.30
1.52 52-week range 16.89
- YTD
- +21.78%
- 1 year
- -46.27%
News
benzinga.com P3 Health Partners Raises FY2026 Sales Guidance from $1.500B-$1.600B to $1.525B-$1.600B vs $1.551B Est P3 Health Partners (NASDAQ:PIII) raises FY2026 sales outlook from $1.500 billion-$1.600 billion to $1.525 billion-$1.600 billion vs $1.551 billion estimate.
benzinga.com P3 Health Partners Q3 EPS $0.07 Beats $(4.79) Estimate, Sales $396.344M Beat $384.800M Estimate P3 Health Partners (NASDAQ:PIII) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $(4.79) by 101.46 percent. This is a 100.72 percent increase over losses…
defenseworld.net Head-To-Head Contrast: Tempus AI (NASDAQ:TEM) versus P3 Health Partners (NASDAQ:PIII) P3 Health Partners (NASDAQ: PIII - Get Free Report) and Tempus AI (NASDAQ: TEM - Get Free Report) are both healthcare companies, but which is the better investment? We will contrast the two…
benzinga.com Why Riot Platforms Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket Riot Platforms Inc (NASDAQ: RIOT) rose sharply in pre-market trading after reporting strong second-quarter financial results.
benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session Gainers P3 Health Partners (NASDAQ:PIII) shares increased by 24.1% to $15.92 during Monday's after-market session. The market value of their outstanding shares is at $38.5 million. As per the press…
benzinga.com P3 Health Partners Narrows FY2026 Sales Guidance from $1.500B-$1.650B to $1.500B-$1.600B vs $1.524B Est P3 Health Partners (NASDAQ:PIII) narrows FY2026 sales outlook from $1.500 billion-$1.650 billion to $1.500 billion-$1.600 billion vs $1.524 billion estimate.
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session Gainers Seer (NASDAQ:SEER) shares rose 32.1% to $2.14 during Monday's pre-market session. The market value of their outstanding shares is at $89.0 million. Innovative Eyewear (NASDAQ:LUCY) stock rose…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session - benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com TD Cowen Maintains Hold on P3 Health Partners, Raises Price Target to $14 TD Cowen analyst Ryan Langston maintains P3 Health Partners (NASDAQ:PIII) with a Hold and raises the price target from $3 to $14.
benzinga.com Why Agilysys Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket Agilysys Inc (AGYS) shares rose in pre-market trading after reporting better-than-expected financial results and issuing positive sales guidance. Other notable gainers and losers in pre-market…
benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session 
benzinga.com What's Going On With P3 Health Partners Stock Monday? P3 Health Partners ($PIII) shares dip Monday as traders lock in profits following a massive 180% Friday surge. Read the full analysis.- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com Why LiveRamp Shares Are Trading Higher By Over 26%; Here Are 20 Stocks Moving Premarket Liveramp Holdings Inc (NYSE: RAMP) rose in pre-market trading after being acquired by Publicis for $2.2 billion. Other gainers include SBFM, NXXT, GOVX, CREG, PMI, ZDAI, GCTS, CMPS, and DXYZ. BTM,…- benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com Lake Street Maintains Buy on P3 Health Partners, Raises Price Target to $14 Lake Street analyst Ben Haynor maintains P3 Health Partners (NASDAQ:PIII) with a Buy and raises the price target from $4 to $14.- benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com Why Figma Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket Figma Inc (NYSE: FIG) shares rose 10.6% in pre-market trading after beating Q1 revenue and earnings estimates and raising FY26 sales guidance.
benzinga.com P3 Health Partners (PIII) Stock Surges Over 42% After Hours: Here's Why P3 Health Partners Inc. shares surged 42.68% in after-hours trading after reporting first-quarter 2026 results that showed a narrower loss than expected.- benzinga.com Full Transcript: P3 Health Partners Q1 2026 Earnings Call
- benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session
benzinga.com P3 Health Partners Narrows FY2026 Sales Guidance from $1.500B-$1.700B to $1.500B-$1.650B vs $1.539B Est P3 Health Partners (NASDAQ:PIII) narrows FY2026 sales outlook from $1.500 billion-$1.700 billion to $1.500 billion-$1.650 billion vs $1.539 billion estimate.
benzinga.com P3 Health Partners Q1 EPS $(1.72) Beats $(3.28) Estimate, Sales $386.390M Miss $391.500M Estimate P3 Health Partners (NASDAQ:PIII) reported quarterly losses of $(1.72) per share which beat the analyst consensus estimate of $(3.28) by 47.56 percent. This is a 72.61 percent increase over losses of…
benzinga.com Earnings Scheduled For May 14, 2026 - benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session
- benzinga.com TD Cowen Maintains Hold on P3 Health Partners, Lowers Price Target to $3 TD Cowen analyst Ryan Langston maintains P3 Health Partners (NASDAQ:PIII) with a Hold and lowers the price target from $8 to $3.
- benzinga.com Lake Street Maintains Buy on P3 Health Partners, Lowers Price Target to $4 Lake Street analyst Ben Haynor maintains P3 Health Partners (NASDAQ:PIII) with a Buy and lowers the price target from $12.5 to $4.
- benzinga.com P3 Health Partners Sees FY2026 Sales $1.500B-$1.700B vs $1.645B Est P3 Health Partners (NASDAQ:PIII) sees FY2026 sales of $1.500 billion-$1.700 billion vs $1.645 billion analyst estimate.
- benzinga.com P3 Health Partners Q4 EPS $(23.02) Misses $(9.46) Estimate, Sales $384.814M Beat $357.650M Estimate P3 Health Partners (NASDAQ:PIII) reported quarterly losses of $(23.02) per share which missed the analyst consensus estimate of $(9.46) by 143.21 percent. This is a 18.05 percent decrease over losses…
- benzinga.com Earnings Scheduled For March 26, 2026
- benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session
- benzinga.com P3 Health Partners, Commonwealth Primary Care Form JV For ACO Lines Of Businesses To Expand Value-Based Care, Enhance Support For Primary Care Physicians Throughout Arizona, California, Nevada, Oregon, and North Carolina P3 Health Partners ("P3") (NASDAQ: PIII) and Commonwealth Primary Care ACO (Commonwealth) recently announced the formation of a Joint Venture Management Services Organization (MSO) for its ACO lines…
- benzinga.com Lake Street Maintains Buy on P3 Health Partners, Lowers Price Target to $12.5 Lake Street analyst Ben Haynor maintains P3 Health Partners (NASDAQ:PIII) with a Buy and lowers the price target from $20 to $12.5.
benzinga.com What's Next: P3 Health Partners's Earnings Preview - benzinga.com P3 Health Partners Affirms FY2025 Sales Guidance of $1.350B-$1.500B vs $1.435B Est P3 Health Partners (NASDAQ:PIII) affirms FY2025 sales outlook from $1.350 billion-$1.500 billion to $1.350 billion-$1.500 billion vs $1.435 billion estimate.
- benzinga.com P3 Health Partners Q2 EPS $(6.23) Misses $(4.11) Estimate, Sales $355.788M Miss $358.223M Estimate P3 Health Partners (NASDAQ:PIII) reported quarterly losses of $(6.23) per share which missed the analyst consensus estimate of $(4.11) by 51.58 percent. This is a 15.47 percent increase over losses…
benzinga.com Earnings Scheduled For August 14, 2025 
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session 
benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session - benzinga.com P3 Health Partners Affirms FY2025 Sales Guidance of $1.35B-$1.50B vs $1.41B Est P3 Health Partners (NASDAQ:PIII) affirms FY2025 sales outlook from $1.35 billion-$1.50 billion to $1.35 billion-$1.50 billion vs $1.41 billion estimate.
- benzinga.com P3 Health Partners Q1 EPS $(6.28) Up From $(7.86) YoY, Sales $373.23M Beat $362.07M Estimate P3 Health Partners (NASDAQ:PIII) reported quarterly losses of $(6.28) per share. This is a 20.1 percent increase over losses of $(7.86) per share from the same period last year. The company reported…
- benzinga.com Earnings Scheduled For May 15, 2025
- benzinga.com What to Expect from P3 Health Partners's Earnings
- benzinga.com Lake Street Maintains Buy on P3 Health Partners, Lowers Price Target to $20 Lake Street analyst Brooks O'Neil maintains P3 Health Partners (NASDAQ:PIII) with a Buy and lowers the price target from $50 to $20.
benzinga.com Medicare Advantage Rates Expected To Climb Over 5% In 2026, Easing Pressure On Managed Care CMS raises 2026 Medicare Advantage payments by 5.06%, exceeding projections and benefiting insurers focused on value-based care.- benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session
- benzinga.com P3 Health Partners Q4 2024 GAAP EPS $(0.36) Misses $(0.09) Estimate, Sales $370.686M Miss $378.056M Estimate P3 Health Partners (NASDAQ:PIII) reported quarterly losses of $(0.36) per share which missed the analyst consensus estimate of $(0.09) by 300 percent. This is a 63.64 percent decrease over losses of…